Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
Former Avadel CEO brings a proven track record of strategic leadership, M&A expertise, and commercial success to lead Mentari as it advances potentially best-in-class therapies for the prevention of migraine Mentari is on-track for regulatory filings to support the advancement of MT-001,...
Read more »